 |
市場調查報告書
商品編碼
1085634
內臟器官保存溶液市場:各溶液類型，各技術類型，各地區-規模，佔有率，展望，機會分析-2022～2028年Organ Preservation Solutions Market, By Solution Type, By Technique Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 |
||||||
價格
簡介目錄
阻礙全球內臟器官保存溶液市場在預測期間內的成長的主要原因，是幹細胞的出現和高成本。
本報告提供全球內臟器官保存溶液市場相關調查分析，市場促進因素，阻礙因素，市場機會，各焊接類型、技術類型、終端用戶、地區市場分析，企業簡介相關資訊。
目錄
第1章 調查目的、前提條件
- 調查目的
- 假設
- 簡稱
第2章 市場展望
- 報告的說明
- 市場定義和範圍
- 摘要整理
- 市場明細:各溶液類型
- 市場明細:各技術類型
- Coherent Opportunity Map(COM)
第3章 市場動態，法規，及趨勢分析
- 市場動態
- 促進因素
- 阻礙因素
- 市場機會
- 影響分析
- 主要的發展
- 法規情境
- PEST分析
- COVID-19影響分析
第4章 全球內臟器官保存溶液市場:各溶液類型(2017～2028年(100萬美元))
- 簡介
- 市場佔有率分析:2022年及2028年(%)
- 與前一年同期比較成長分析:2017～2028年
- 市場區隔趨勢
- Viaspan
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 市場區隔趨勢
- Custodiol HTK
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 市場區隔趨勢
- Renograf
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 市場區隔趨勢
- Hypothermosol
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 市場區隔趨勢
- Perfadex
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 市場區隔趨勢
- Lifor
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 市場區隔趨勢
- HBS溶液
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 市場區隔趨勢
- siRNA
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 市場區隔趨勢
- 其他
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 市場區隔趨勢
第5章 全球內臟器官保存溶液市場:各技術類型(2017～2028年(100萬美元))
- 簡介
- 市場佔有率分析:2022年及2028年(%)
- 與前一年同期比較成長分析:2017～2028年
- 市場區隔趨勢
- 低體溫灌流保存
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 靜態冷資料儲存(SCS)
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 其他
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
第6章 全球內臟器官保存溶液市場:各終端用戶(2017～2028年(100萬美元))
- 簡介
- 市場佔有率分析:2022年及2028年(%)
- 與前一年同期比較成長分析:2017～2028年
- 市場區隔趨勢
- 公共/民間的醫療機關
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 醫生
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 醫護人員
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 個人
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
第7章 全球內臟器官保存溶液市場:各地區(2017～2028年(100萬美元))
- 簡介
- 市場佔有率分析:2022年及2028年(%)
- 與前一年同期比較成長分析:2017～2028年
- 市場區隔趨勢
- 北美
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 美國
- 加拿大
- 歐洲
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
- 亞太地區
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 中國
- 印度
- 日本
- 東南亞國家聯盟
- 澳洲
- 韓國
- 其他亞太地區
- 南美
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 巴西
- 墨西哥
- 阿根廷
- 其他南美國家
- 中東
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 海灣合作理事會
- 以色列
- 其他中東
- 非洲
- 簡介
- 市場規模與預測，及與前一年同期比較成長率:2017～2028年(100萬美元))
- 北非
- 中非
- 南非
第8章 競爭情形
- 企業簡介
- Teva Pharmaceutical Industries Ltd.
- Dr. Franz Kohler Chemie GmbH
- BioLife Solutions
- XVIVO Perfusion AB
- Bristol-Myers Squibb, Inc.
- ToleroTech, Inc.
- Lifeline Scientific
- Preservation Solutions Inc.
- Claris Injectables Limited
- 21st Century Medicine
- Paragonix Technologies Inc.
- BioTime, Inc.
- CryoLife, Inc.
第9章 Section
簡介目錄
Product Code: CMI1072
Organ preservation involves removal of organs from the bodies, which are then stored for transplantation. Organ preservation systems are exclusively prepared and maintained according to the biological environment (temperature and oxygen) needed to store particular organs. Different body organs require specific and suitable storage conditions to maintain their anatomical and physiological processes. Important parameters in organ preservation include delivering of high quality organs to the donors, matching the patient and organ suitability, and restart of life of the organs and sustaining functions after the transplantation. Organ transplantation process starts with removing the needed organ from the donor body, then the organ is stored and transported.
Restraints of the Global Organ Preservation Solutions Market
Major factors hampering the growth of the organ preservation solutions market during the forecast period constitutes of advent of stem cells, and high costs.
Key features of the study:
- This report provides in-depth analysis of the global organ preservation solutions market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global organ preservation solutions market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Dr. Franz Kohler Chemie GmbH, BioLife Solutions, XVIVO Perfusion AB, Bristol-Myers Squibb, Inc., and ToleroTech, Inc., Lifeline Scientific, Preservation Solutions Inc., Claris Injectables Limited, 21st Century Medicine, Paragonix Technologies Inc., BioTime, Inc. CryoLife, Inc., and Dr. Franz Kohler Chemie GmbH.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global organ preservation solutions market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
- Global Organ Preservation Solutions Market, By Solution Type:
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- Global Organ Preservation Solutions Market, By Technique Type:
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- Global Organ Preservation Solutions Market, By Geography:
- North America
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country:
- U.S.
- Canada
- Europe
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country:
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East:
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Solution Type
- Viaspan
- Custodiol HTK
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- HBS Solution
- siRNA Transplant Solutions
- Others
- By Technique Type
- Hypothermic Perfusion Preservation
- Static Cold Storage
- Others
- By Country/Region:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Teva Pharmaceutical Industries Ltd.*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Dr. Franz Kohler Chemie GmbH
- BioLife Solutions
- XVIVO Perfusion AB
- Bristol-Myers Squibb, Inc.
- ToleroTech, Inc.
- Lifeline Scientific
- Preservation Solutions Inc.
- Claris Injectables Limited
- 21st Century Medicine
- Paragonix Technologies Inc.
- BioTime, Inc.
- CryoLife, Inc.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Solution Type
- Market Snippet, By Technique Type
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
4. Global Organ Preservation Solutions Market, By Solution Type, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Viaspan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Custodiol HTK
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Renograf
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Hypothermosol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Perfadex
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Lifor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- HBS Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- siRNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
5. Global Organ Preservation Solutions Market, By Technique Type, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hypothermic Perfusion Preservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Static Cold Storage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Organ Preservation Solutions Market, By End User, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Public/Private healthcare institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Physicians
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Healthcare workers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Individuals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Organ Preservation Solutions Market, By Regions, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dr. Franz Kohler Chemie GmbH
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioLife Solutions
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- XVIVO Perfusion AB
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ToleroTech, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lifeline Scientific
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Preservation Solutions Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Claris Injectables Limited
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 21st Century Medicine
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Paragonix Technologies Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioTime, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CryoLife, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Section
- References
- Research Methodology
- About us and Sales Contact
02-2729-4219
+886-2-2729-4219
器官保存市場評估：按解決方案、技術、器官類型、最終用戶和地區劃分的機會和預測（2017-2031）
2024-2032 年器官保存市場報告（按保存解決方案、器官捐贈類型、技術、器官類型、最終用戶和地區）
2024 年全球器官保存解決方案市場報告
到 2030 年器官保存解決方案市場預測：按解決方案、保存類型、器官、最終用戶和地區進行的全球分析
器官保存解決方案市場- 按解決方案（威斯康辛大學、Custodiol HTK、Perfadex、Celsior）、保存類型（靜態冷藏、低溫、常溫）、器官（腎、肝、肺）、最終用戶、全球預測（2023年- ）第2032章
2023-2027年全球器官保存市場
亞太地區器官保存解決方案市場預測至 2028 年 - COVID-19 影響和區域分析 - 按類型、應用程式、器官類型和最終用戶
北美器官保存解決方案市場預測至 2028 年 - COVID-19 影響和區域分析 - 按類型、應用程式、器官類型和最終用戶
南美洲和中美洲器官保存解決方案市場預測至 2028 年 - COVID-19 影響和區域分析 - 按類型、應用程式、器官類型最終用戶
歐洲器官保存解決方案市場預測至 2028 年 - COVID-19 影響和區域分析 - 按類型、應用程式、器官類型和最終用戶
▼